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This paper reports on the effects of both reducing and nonreducing transgalactooligosaccharides (TOS)
comprising 2 to 8 residues on the growth of Bifidobacterium adolescentis DSM 20083 and on the production of
a novel b-galactosidase (b-Gal II). In cells grown on TOS, in addition to the lactose-degrading b-Gal (b-Gal
I), another b-Gal (b-Gal II) was detected and it showed activity towards TOS but not towards lactose. b-Gal
II activity was at least 20-fold higher when cells were grown on TOS than when cells were grown on galactose,
glucose, and lactose. Subsequently, the enzyme was purified from the cell extract of TOS-grown B. adolescentis
by anion-exchange chromatography, adsorption chromatography, and size-exclusion chromatography. b-Gal II
has apparent molecular masses of 350 and 89 kDa as judged by size-exclusion chromatography and sodium
dodecyl sulfate-polyacrylamide gel electrophoresis, respectively, indicating that the enzyme is active in vivo as
a tetramer. b-Gal II had an optimal activity at pH 6 and was not active below pH 5. Its optimum temperature
was 35°C. The enzyme showed highest Vmax values towards galactooligosaccharides with a low degree of
polymerization. This result is in agreement with the observation that during fermentation of TOS, the di- and
trisaccharides were fermented first. b-Gal II was active towards b-galactosyl residues that were 134, 136,
133, and 171 linked, signifying its role in the metabolism of galactooligosaccharides by B. adolescentis.
The human colonic flora has both beneficial and pathogenic
potential with respect to host health. There is now much in-
terest in the manipulation of the microbiotic composition of
the colon in order to improve the potentially beneficial effects
of the microorganisms (10). Probiotics are live microbial sup-
plements which beneficially affect the host by improving its
intestinal microbial balance (7, 9) and have been used for many
years for this reason. As the viability of live bacteria in food
products and during transit through the gastrointestinal tract
may be variable, the concept of prebiotics has been developed.
A prebiotic is considered to affect the host beneficially by
selectively stimulating the growth and/or activity of one or a
limited number of naturally present or introduced bacterial
species in the colon. It has been claimed that this will also lead
to an improvement in host health (11). Increasingly, probiotics
and prebiotics are used in combination and are called synbi-
otics (4, 7, 32). Fructooligosaccharides are considered prebi-
otics (10), and oral dosages of transgalactooligosaccharides
(TOS) appear to result in increased numbers of bifidobacteria
in the human fecal flora (2, 12, 13). It is claimed that a high
number of bifidobacteria is beneficial for the health of the host.
This may prevent colonization by pathogens and may have
positive effects on intestinal peristalsis, on the immune system,
in cancer prevention, on cholesterol metabolism, and on car-
bohydrate metabolism in the colon (11, 17).
TOS are oligosaccharides produced by transgalactosylation
of lactose using a b-galactosidase (b-Gal). The linkage be-
tween the galactose units and the components in the final
product depend on the enzymes and the conditions used in the
reaction. The production and characterization of these TOS
have been described in various publications (19, 21, 25). Dif-
ferent linkages between galactose and the reducing glucose
unit have been identified, namely, b-D-Galp-(132)-D-Glcp,
b-D-Galp-(133)-D-Glcp, b-D-Galp-(134)-D-Glcp, and b-D-
Galp-(132)-D-Glcp. Also, branched Glcp residues occur,
whereas oligogalactose fragments contain mainly 134 or 136
linkages (26, 33). Recently, Fransen et al. (8) showed that
nonreducing galactooligosaccharides were also formed during
transgalactosylation of lactose.
Up to now no information has been available about the
contribution of the various oligosaccharides in TOS to growth
of Bifidobacterium species, and nothing is known about their
effect on the synthesis and activities of enzymes involved in
oligosaccharide metabolism. Only artificial substrates, such as
para-nitrophenyl b-D-galactoside, have been used to determine
b-Gal activities in bifidobacteria (1, 5, 6, 22, 23, 27, 28). How-
ever, the use of such substrates does not supply information
about the number of enzymes involved and their specificities.
Using classical culture methods and also molecular techniques,
it was shown that Bifidobacterium adolescentis is a major bi-
fidobacterial species in the adult intestinal microflora (16, 18).
In this paper we focus on the fermentation of various oligo-
saccharides in TOS by B. adolescentis. In addition to a lactose-
degrading b-Gal (b-Gal I), a novel b-Gal (b-Gal II) involved in
the degradation of TOS was purified and characterized. The
role of the enzyme in the metabolism of TOS by B. adolescentis
is discussed.
MATERIALS AND METHODS
Substrates. TOS were obtained by transgalactosylation of lactose with a b-Gal.
The TOS mixture (Borculo Whey Products, Borculo, The Netherlands) was
partially purified using charcoal chromatography in order to decrease the levels
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of mono- and disaccharides. The enriched oligosaccharide mixture contained
99% oligomers as well as some residual galactose, glucose, and lactose.
Enriched fractions containing [b-D-Galp-(136)]n-D-Glcp and [b-D-Galp-
(134)]n-D-Glcp were obtained by fractionation of TOS from, respectively, Oli-
gomate-50 (Yakult Pharmaceutical Co. Ltd.) and CUP-oligo (Nissin Sugar, To-
kyo, Japan). Enriched fractions containing [b-D-Galp-(134)]n-D-Galp (n 5 1 to
3) were obtained by incubation of extracted soy arabinogalactan with an endo-
galactanase. After partial purification, their structure was confirmed using nu-
clear magnetic resonance spectroscopy. [b-D-Galp-(134)]n-D-Glcp (n 5 2 to 3)
and b-D-Galp-(131)-D-Glcp were purified and characterized as described by
Fransen et al. (8). 39 Fucosyllactose, lacto-N-fucopentaose I, lacto-N-fucopen-
taose II, and b-D-Galp(136)-D-Galp were obtained from Dextra Laboratories
Ltd. (Reading, United Kingdom), b-D-Galp(133)-Araf was obtained from ICN
Biomedicals Inc. (Aurora, Ohio). p-Nitrophenyl (NP)-glycosides were obtained
from Sigma (St. Louis, Mo.) or from Koch and Light, Ltd. (Haverhill, United
Kingdom). Lactulose was obtained from Solvay (Weesp, The Netherlands).
Melibiose was obtained from Jansens Chimica (Beerse, Belgium). Other chem-
icals were of analytical grade and obtained from commercial sources.
Bacterial strain, culture conditions, and oligosaccharide fermentation. B.
adolescentis DSM 20083 was obtained from the Deutsche Sammlung von Mik-
roorganismen und Zelkulturen GmbH (Braunschweig, Germany). Cell extracts
were prepared from B. adolescentis grown in M17 broth (Oxoid, Hampshire,
England) for 48 h at 37°C in an anaerobic chamber with an atmosphere consist-
ing of CO2 (10%), H2 (10%), and N2 (80%). The pH of the medium was adjusted
to pH 6.5 with KOH prior to sterilization. Sugars (TOS, melibiose, lactose,
galactose, and glucose) (0.5% [wt/vol] sugars in the M17 medium) were added
from filter-sterilized stock solutions.
Analysis of TOS. TOS from Borculo Whey Products, Yakult, and Nissin were
fractionated by Bio-Gel P-2 gel size-exclusion chromatography (100 by 2.6 cm
with a 200/400 mesh (Bio-Rad) and with the column thermostated at 60°C, using
a Pharmacia Hiload system equipped with a Pharmacia P50 pump. A Shodex
RI-72 detector was used to monitor the refractive index of the water used as the
eluent (0.3 ml/min). The oligosaccharide compositions of various fractions were
established using high-performance anion-exchange chromatography (HPAEC).
For this purpose a Bio-LC system (Dionex, Sunnyvale, Calif.) that included a
quaternary gradient pump, an eluent degas (He) module, and a 4- by 250-mm
Carbopac PA100 column with matching guard column (pulsed amperometric
detection mode) was used. Samples (20 ml) were injected into the system using
a Spectra Physics (San Jose, Calif.) SP8800 autosampler, and chromatograms
were recorded using a PC 1000 system. The sodium acetate gradient (1 ml/min)
in 100 mM NaOH was for 0 to 30 min with a linear gradient of 0 to 200 mM. The
effluent was monitored using a pulsed electrochemical detector detector con-
taining a gold electrode with an Ag-AgCl reference electrode. The column was
washed for 5 min with 1 M sodium acetate and equilibrated again for 15 min with
100 mM NaOH before the next run was performed.
Preparation of cell extracts. B. adolescentis DSM 20083 was grown as de-
scribed previously, and the cells were harvested by centrifugation (10,000 3 g, 10
min, 4°C) upon reaching the stationary phase. Cells were washed once in 20 mM
phosphate buffer (pH 6.5) and then resuspended in 10 ml of the same buffer.
Cells were disrupted on ice by sonic treatment (15 min; duty cycle, 30%).
Subsequently, the suspension was centrifuged at 10,000 3 g for 10 min to remove
nondisrupted cells and the resulting supernatant was centrifuged at 30,000 3 g
for 60 min to pellet cell debris. The supernatants (enzyme extracts) were filter
sterilized and assayed for enzyme activity. The protein contents of the enzyme
extracts were determined using the method of Bradford (3) with bovine serum
albumin as a standard.
Enzyme assays. b-Gal activity was measured by determining the hydrolysis of
p-NP-b-D-galactopyranoside (PNPG) at 40°C after 60 min of incubation. The
reaction mixture (125 ml) contained 75 ml of 50 mM phosphate buffer (pH 6), 25
ml of 0.1% PNPG solution, and 25 ml of cell extract. The increase in adsorbance
(405 nm) was measured. A unit of enzyme activity was defined as 1 mmol of
galactose liberated per min in 50 mM phosphate buffer (pH 6) at 40°C. The
molar extinction coefficient under these assay conditions was 13,700 M21 cm21.
The hydrolytic activities of b-Gal on TOS and the different oligosaccharides
and polysaccharides were calculated from the amount of galactose released as
determined by HPAEC. The incubation was performed at 40°C for 1 h, and the
reaction mixture consisted of 100 ml of 0.1% (wt/vol) substrate in 50 mM phos-
phate buffer (pH 6).
Production and purification of b-Gal II. b-Gal II was purified from the crude
enzyme extract from B. adolescentis grown on 0.5% (wt/vol) TOS. Unless stated
otherwise, all procedures were carried out at room temperature. All buffers
contained 0.01% (wt/vol) sodium azide to prevent microbial growth. Collected
fractions were screened for protein content (A280 or the Sedmak method) and for
b-Gal activity.
The purification steps of the enzyme extract involved Bio-Gel HTP hydroxy-
apatite (Bio-Rad Laboratories, Richmond, Calif.), Q-Sepharose, Mono Q
HR5/5, and Sephacryl S200 HR16/60. The last three columns were from Phar-
macia LKB Biotechnology, Uppsala, Sweden.
pH and temperature optimum of b-Gal II at the conditions used. The opti-
mum temperature of b-Gal II was determined by incubation of the b-Gal with
0.1% (wt/vol) TOS in 50 mM phosphate buffer (pH 7) at 20, 30, 35, 40, 45, 50,
60°C for 1 h. The optimum pH was determined by incubating the b-Gal with
0.1% (wt/vol) TOS in citrate-phosphate buffer in a pH range of 2.5 to 8.0 for 1 h
at 40°C.
Kinetic parameters of b-Gal II. Different substrates [PNPG, lactose, b-D-
Galp-(134)-b-D-Galp-(134)-D-Glcp, b-D-Galp-(134)-b-D-Galp-(134)-b-D-Galp-
(134)-D-Glcp, b-D-Galp-(134)-D-Galp, b-D-Galp-(134)-b-D-Galp-(134)-D-Galp,
or b-D-Galp-(134)-b-D-Galp-(134)-b-D-Galp-(134)-D-Galp] with concentra-
tions ranging from 0.1 to 30 mM in a 50 mM phosphate buffer (200-ml total
volume, pH 6.0) were incubated with b-Gal II (0.025 mg of protein/200 ml) at
40°C for 1 h. The Km and catalytic constant values were calculated from the
initial rates of the hydrolyses of oligosaccharides. Data analysis for calculation of
kinetic parameters, using nonlinear regression, was performed with the Enzfitter
program (Biosoft, Cambridge, United Kingdom).
Gel electrophoresis. Native electrophoresis and sodium dodecyl sulfate-poly-
acrylamide gel electrophoresis (PAGE) were carried out with a PhastSystem
(Pharmacia LKB Biotechnology) according to the instructions of the supplier by
using a 8 to 25% polyacrylamide gel or a 10 to 15% polyacrylamide gel (Phar-
macia LKB Biotechnology).
Activity staining in acrylamide gels. Different enzyme extracts each containing
2 mg of protein were loaded and electrophoresed on a nondenaturing PAGE
system (Pharmacia LKB Biotechnology). b-Gal activity was detected by incubat-
ing the gel in a 49 umbelliferyl b-Galactoside solution (1 mg/ml in 50 mM
phosphate buffer, pH 7). Fluorescent bands were visualized under UV light and
photographed after incubation for 5 and 60 min.
RESULTS
Composition of the TOS mixture. The TOS mixture was
composed mainly of oligosaccharides (99%) and small
amounts of residual galactose (0.1%), glucose (0.3%), and
lactose (0.6%). In order to determine the degrees of polymer-
ization of the oligosaccharides present, the oligosaccharide
mixture was subjected to size-exclusion chromatography on a
Bio-Gel P-2 column. Fractions corresponding to a given peak
were pooled and subjected to HPAEC. All fractions were
found to contain several components (data not shown) having
the same degree of polymerization (8). In Fig. 1 the HPAEC
elution profile of the complete TOS mixture is given and the
degrees of polymerization of the various peaks are indicated.
The TOS mixture contains 0.5, 2, 6, 17, 37, 27, 8.5, and 2%
mono-, di-, tri-, tetra-, penta-, hexa-, hepta-, and octamers,
respectively, as determined using a refractive index. The struc-
tures of the purified oligosaccharides are described elsewhere
(8).
Degradation of TOS by B. adolescentis. B. adolescentis grown
in M17 containing glucose (0.5% [wt/vol]) (GM17) was trans-
ferred to fresh M17 medium (anaerobic, batch) containing
0.5% (wt/vol) TOS. The growth (optical density) and acidifi-
cation (pH) of the culture were measured (Fig. 2), and residual
TOS was analyzed using HPAEC (Fig. 3). After a lag phase in
which no carbohydrates were fermented (Fig. 3A), exponential
growth occurred. At the beginning of this exponential growth
phase only monomeric material was fermented. At the end of
the first exponential growth phase dimeric material and part of
the trimeric material were fermented (Fig. 3B). Upon reaching
an optical density of 0.6, a second lag phase occurred. In the
second exponential growth phase oligomers with a DP of $3
were fermented (Fig. 3C), with the low-DP oligosaccharides
being fermented first. Some residual TOS was observed after
50 h (Fig. 3D), which may have been due to inactivation of the
enzyme at the low pH value reached at this point of fermen-
tation (Fig. 2 and see below). When B. adolescentis was pre-
cultured on TOS, no biphasic growth could be observed and
the stationary phase was reached within 30 h. These results
suggest that cells have adapted to metabolize TOS more effi-
ciently.
Glycosidase activities in B. adolescentis. Subsequently, gly-
cosidase activities in different cell extracts were determined
with PNPG as a substrate. Specific b-Gal activity was highest in
cells grown on TOS (Table 1). Surprisingly, other glycosidase
activities were also higher in TOS-grown cells, including a-Gal,
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b-glucosidase, b-xylosidase, and a-L-arabinofuranosidase. Al-
though high levels of glycosidases were present, no endo-gly-
canase activity could be detected.
The activities of enzyme extracts from lactose- and TOS-
grown cells towards TOS-pentamer were analyzed by deter-
mining the release of galactose residues (Fig. 4). The amount
of galactose released by the enzyme extract from TOS-grown
cells was approximately 20-fold higher than that with enzyme
extract of lactose-grown cells. Comparable low amounts of
galactose were also released with enzyme extracts from galac-
tose- and glucose-grown cells (data not shown).
b-Gal activities of enzyme extracts from galactose-, glucose-,
lactose-, and TOS-grown B. adolescentis were also assayed af-
ter PAGE under nondenaturating conditions using 49 umbel-
liferyl b-galactoside as the substrate (Fig. 5). In extracts from
galactose-, glucose-, and lactose-grown cells one b-Gal band
(b-Gal I) was observed, whereas in extracts from TOS-grown
cells, besides b-Gal I, the band of which exhibited an increased
intensity, a second b-Gal (b-Gal II) was detected. This second
activity band was only faintly visible after prolonged incubation
with cell extracts from galactose-, glucose-, and lactose-grown
cells (data not shown), indicating that this enzyme is indeed
present at very low levels in cells grown on sugars other than
TOS (see below).
Purification and characterization of b-Gal II. B. adolescentis
was grown on M17 and TOS, and after reaching stationary
phase, cells were harvested and the enzyme extract was pre-
pared. No b-Gal activity could be detected in the culture su-
pernatant. The enzyme extract contained 2 g of protein, and a
total b-galactosidase activity of 880 U towards PNPG was
measured. Cell extract from B. adolescentis was fractionated
using Q-Sepharose, Bio-Gel HTP hydroxyapatite, Mono Q
HR5/5, and Sephacryl S200 HR16/60. The Q-Sepharose sepa-
ration resulted in the separation of two different b-Gal’s (b-
Gal I and b-Gal II). The b-Gal II-containing fraction showed
activity towards TOS and no activity towards lactose, while the
b-Gal I-containing fraction was active towards lactose and not
towards TOS. The TOS-active b-Gal II action was purified
further on a Sephacryl S200 column and MonoQ column, and
this resulted in an electrophoretically pure b-Gal II prepara-
tion (not shown). The molecular mass was approximately 350
kDa, as estimated using Superose 12. By sodium dodecyl sul-
FIG. 1. HPAEC elution pattern of TOS. Numbers 1 to 8 indicate monomers, dimers, trimers, tetramers, pentamers, hexamers, heptamers, and octamers,
respectively. Peaks 3a, 4a, and 5a have been identified as 49 galactosyllactose, 49 galactosyl galactosyl lactose, and 49 galactosyl galactosyl galactosyl lactose, respectively.
Note that peak areas do not supply information about the concentrations of the oligosaccharides, since the response factors of the pulsed electrochemical detector vary
significantly with the various oligomers, with lowest responses occurring with oligosaccharides with a high DP. PAD, pulsed amperometric detection.
FIG. 2. Growth of B. adolescentis in M17 containing 0.5% (wt/vol) TOS.
Cells were precultured in M17 containing 0.5% (wt/vol) glucose. Arrows A to D
indicate at which times samples were taken for HPAEC analysis of TOS in the
supernatant (see Fig. 3). OD, optical density.
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fate-PAGE, a single protein band was found at 89 kDa, sug-
gesting that the enzyme is active as a tetramer in vivo.
Substrate specificity and kinetic experiments with b-Gal II.
Subsequently, substrate specificity and physicochemical prop-
erties of b-Gal II were determined. Using PNPG, the enzyme
had a specific activity of 5.5 U/mg and optimal activity at pH 6
and 35°C. b-Gal II was tested on a range of substrates. b-Gal
II was active towards the nonreducing oligosaccharide b-D-
Galp-(171)-D-Glcp and to the other oligosaccharides present
in the mixture, including TOS (with a DP of 8) (data not
shown). Activity was also observed towards the galactooligo-
saccharides of other origins, such as b-D-Galp-(133)-Araf,
b-D-Galp-(136)-D-Galp, [b-D-Galp-(136)]n-D-Glcp (n 5 2 to
3), and [b-D-Galp-(134)]n-D-Galp (n 5 1 to 3). The enzyme
showed no detectable activity towards lactose, lactulose, 39
fucosyllactose, lacto-N-fucopentaose I, or lacto-N-fucopen-
taose II. Incubation of b-Gal II in assays with increasing con-
centrations of b134-linked galactooligosaccharides resulted in
hyperbolic plots of substrate versus reaction rate, indicating
typical Michaelis-Menten saturation kinetics. Km and Vmax val-
ues for the enzyme towards different galactooligosaccharides
and PNPG are given in Table 2. These data clearly show a
general decrease in the Vmax and catalytic efficiency (expressed
as Vmax/Km) of b-Gal II with an increase in the size of the
oligosaccharides.
DISCUSSION
This paper reports on the isolation and characterization of a
novel b-Gal (b-Gal II) from B. adolescentis, active towards
TOS. B. adolescentis produces two different b-Gal’s when it is
cultured on TOS. The first one (b-Gal I), which was also
detected in cells grown on glucose, galactose, and lactose,
appeared to be active towards lactose but not towards TOS.
The TOS-active b-Gal II was present at high levels only in
FIG. 3. HPAEC elution pattern of TOS fermented by B. adolescentis. Sam-
ples were taken at 14 h (A), 22 h (B), 40 h (C), and 50 h (D) (see Fig. 2). m1, m2,
m3, and m4 are components present in M17 broth. Numbers 1 to 8 indicate
monomers, dimers, trimers, tetramers, pentamers, hexamers, heptamers, and
octamers, respectively. Peaks 3a, 4a, and 5a have been identified as 49 galacto-
syllactose, 49 galactosyl galactosyl lactose, and 49 galactosyl galactosyl galactosyl
lactose, respectively. PAD, pulsed amperometric detection.
FIG. 4. HPAEC elution patterns of galactopentasaccharides before (A) and
after (B and C) degradation with the enzyme extracts of B. adolescentis grown on
lactose (B) and on TOS (C). Galp, galactose; p, pentamers; O, oligosaccharides
formed by degradation of the galactopentasaccharides; PAD, pulsed ampero-
metric detection.
TABLE 1. Specific enzyme activities in cell extracts from
B. adolescentis DSM 20083 grown in the presence of
different substrates
p-NP-glycoside
Sp act (mU/mg of protein) on growth substrate:
Galp Glcp Lactose TOS Melibiose
p-NP-a-Galp 530 995 745 2,430 2,220
p-NP-b-Galp 65 155 40 1,820 15
p-NP-a-Glcp 10 270 30 100 900
p-NP-b-Glcp 240 270 200 1,010 235
p-NP-b-Xylp 60 80 55 300 75
p-NP-a-Araf 5 10 5 50 10
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TOS-grown cells, indicating that synthesis is induced by the
substrate. b-Gal II was subsequently characterized further and
was optimally active at pH 6 and 35°C, conditions mimicking
those found in the colon. Remarkably, purified b-Gal II
showed no activity at pH 5 and below, which may affect the
action of the enzyme in environments such as the colon, where
the pH may decrease below pH 6 due to microbial production
of short-chain fatty acids. b-Gal II was active toward all the
oligosaccharides present in the TOS mixture, including those
with high DP. Kinetic characterization of b-Gal II revealed
highest Vmax values towards oligosaccharides with low DP,
which is in line with the sequential degradation observed dur-
ing TOS fermentation. The b-Gal II was also active towards
b-galactooligosaccharides derived from soy. However, b-Gal II
showed no activity towards fucosylated galactooligosaccharides
isolated from human milk. The nonreducing disaccharide b-D-
Galp-(171)-D-Glcp isolated by Fransen et al. (8) from the
TOS mixture was completely hydrolyzed into galactose and
glucose monomers, indicating that these novel types of nonre-
ducing oligosaccharides can be degraded by B. adolescentis.
Since microbial sugar transport systems described so far can
take up monomers, dimers, or trimers (20), it is speculated that
b-Gal II, in contrast to lactose-hydrolyzing b-Gal I, is located
extracellularly. It is conceivable that the enzyme is cell wall or
membrane attached, since no activity was found in the culture
supernatant. With TOS, extracellularly released galactose res-
idues from TOS by b-Gal II would be accumulated via a ga-
lactose transport system and subsequently metabolized. The
final remaining lactose may be taken up via a lactose transport
system (14, 20) and split intracellularly by b-Gal I, and the
galactose and glucose residues may then metabolized. Several
other B. adolescentis enzymes active towards large extracellular
substrates were not found in the supernatant, which indicates
that they are cell wall or membrane bound (30, 31). The re-
cently characterized (15) and cloned (29) a-Gal showing activ-
ity towards a-galactooligosaccharides was shown to possess a
signal sequence, which indicates that the enzyme is translo-
cated to and active on the outside of the cell. Also, two arabi-
noxylan arabinofuranohydrolases from B. adolescentis were
supposed to be membrane or cell wall associated and to de-
grade an extracellular substrate, as they are active towards
arabinose-containing xylooligosaccharides which contain up to
10 sugar units (30, 31). Whether the binding of these glycosi-
dases to the cell wall provides a competitive advantage, e.g., in
releasing substrates at the cell surface, remains to be eluci-
dated.
The utilization of the trisaccharides 49 galactosyllactose and
69 galactosyllactose by intestinal bacteria has been studied pre-
viously (24), and it has been shown that these substrates are
fermented not only by bifidobacteria but also by Lactobacillus,
Bacteroides, and Clostridium species. It is conceivable that
these bacteria produce b-Gal’s active towards these trisaccha-
rides. So far the utilization of galactooligosaccharides with a
higher degree of polymerization has not been reported. Our
work shows that B. adolescentis can degrade also oligosaccha-
rides with a DP of .3 under these conditions. Other tested
bacteria such as Bifidobacterium infantis and Lactobacillus aci-
dophilus could utilize only the TOS with a DP of #3 present in
the mixture (data not shown). Metabolism of high concentra-
tions of TOS by B. adolescentis is linked to the production of
b-Gal II, which is active towards these oligosaccharides. This
enzyme might allow B. adolescentis to utilize the oligosaccha-
rides more efficiently than other microorganisms. Therefore,
this TOS mixture, containing mainly higher-molecular-weight
material, might be an interesting prebiotic substrate, as it is
metabolized by B. adolescentis, one of the predominant human
fecal bacteria (16).
Strikingly, during growth of B. adolescentis on TOS a large
number of glycosidases are produced, including two arabino-
furanohydrolases which are involved in the degradation of
arabinoxylooligosaccharides (30, 31). This may offer an addi-
tional competitive advantage, since it allows the organism to
scavenge the environment for a range of substrates and use the
degradation products for growth. No endo-glycanase activity
could be detected in the cell extract (data not shown), suggest-
FIG. 5. b-Gal activity staining on a nondenaturing polyacrylamide gel. Crude
enzyme preparations of B. adolescentis DSM 20083 grown on galactose (lane 1),
glucose (lane 2), lactose (lane 3), and TOS (lane 4), with each preparation
containing 2 mg of protein, were supplied to the gel. b-Gal activity was visualized
under UV light after 5 min of incubation with a 49 umbelliferyl b-galactoside
solution.
TABLE 2. Kinetic parameters of b-Gal II from B. adolescentis
Substrate Km (mM) Vmax (U/ml) Vmax/Km
PNPG 2.2 6 0.2 5.0 6 0.2 2.3
b-D-Galp-(134)-D-Glcp 0 0
b-D-Galp-(134)-b-D-Galp-(134)-D-Glcp 2.2 6 0.2 93.0 6 3.5 42.2
b-D-Galp-(134)-b-D-Galp-(134)-b-D-Galp-(134)-D-Glcp 4.0 6 0.4 68.1 6 3.2 17.0
b-D-Galp-(134)-D-Galp 3.7 6 0.3 95.3 6 2.4 25.7
b-D-Galp-(134)-b-D-Galp-(134)-D-Galp 6.4 6 0.2 48.6 6 0.5 7.6
b-D-Galp-(134)-b-D-Galp-(134)-b-D-Galp-(134)-D-Galp 5.2 6 0.7 17.2 6 0.8 3.3
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ing that B. adolescentis adopted a strategy aimed at utilizing
polysaccharide degradation products generated by other mi-
croorganisms instead of taking part in the initial depolymer-
ization stage of polysaccharides.
The obtained results provide new insights into the oligosac-
charide metabolism of bifidobacteria. Furthermore, the induc-
tion of b-Gal II during growth on TOS indicates that optimal
performance of a synbiotic product containing B. adolescentis
(probiotic) and TOS (prebiotic) can be obtained only by pre-
culturing the microorganism on this substrate.
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